VACCINOLOGY

-
Hi Folks!! Follow our blog on Instagram.

Vaccinology is an interdisciplinary field dedicated to the study, development, and application of vaccines to prevent infectious diseases. Here's a deeper dive into its critical aspects:




Vaccine Development

      1. Live-Attenuated Vaccines
  • Contains weakened forms of the pathogen.
  • Example: Measles, Mumps, Rubella (MMR) vaccine.
  • Advantage: Strong immune response with long-lasting immunity.
  • Risk: Not suitable for immunocompromised individuals.
      2. Inactivated Vaccines
  • Contain killed pathogens.
  • Example: Polio (IPV), Hepatitis A vaccines.
  • Advantage: Safe for most individuals.
  • Limitation: Often require booster doses.
      3. Subunit Vaccines
  • Include only parts of the pathogen, like proteins.
  • Example: Hepatitis B, HPV vaccines.
  • Benefit: Minimal risk of side effects.
      4. mRNA Vaccines
  • Use messenger RNA to instruct cells to produce antigenic proteins.
  • Example: Pfizer-BioNTech and Moderna COVID-19 vaccines.
  • Advantage: Rapid production; highly effective.
      5. Viral Vector Vaccines
  • Use a harmless virus to deliver genetic material coding for an antigen.
  • Example: Johnson & Johnson COVID-19 vaccine.
  • Benefit: Strong and targeted immune response.
      6. DNA Vaccines
  • Introduce DNA coding for antigens directly into host cells.
  • Example: In development for Zika and some cancers.
  • Advantage: Stable and scalable.
Stages of Development

     1. Exploratory Phase
  • Basic research on the pathogen and its antigens.
     2. Preclinical Phase
  • Laboratory and animal studies to assess immune response and safety.
     3. Clinical Trials
  • Phase I: Small group testing for safety and immune response.
  • Phase II: Larger group testing for optimal dosage and expanded safety.
  • Phase III: Thousands of participants will be asked to confirm efficacy and monitor rare side effects. 
Regulatory Approval
  • Submission to authorities like the FDA or WHO for licensing.
Post-Marketing Surveillance (Phase IV)
  • Continuous monitoring for long-term effects and rare adverse events.

Mechanisms of Action

Innate Immunity - The first line of defense triggered by adjuvants in vaccines (e.g., aluminum salts).
Adaptive Immunity  - B cells produce antibodies to neutralize pathogens.                                                                                   - T cells destroy infected cells and provide long-term memory.
Immune Memory - Vaccines train the immune system to remember the pathogen, allowing for a faster and stronger response upon re-exposure.

Vaccine Testing and Efficacy

Safety Assessments
  • Monitor for potential side effects, including rare adverse events.
Efficacy Studies
  • Measure how well the vaccine prevents disease in a controlled environment.
Effectiveness in Real-World Use
  • Studies measure the reduction in disease incidence post-vaccine rollout.


Epidemiology and Herd Immunity

Herd Immunity
  • It occurs when a critical portion of the population is immune, reducing the spread of disease.
  • Threshold varies: Measles (~95%), Polio (~80%).
Disease Eradication
  • Example: Smallpox eradication achieved through global vaccination campaigns.
 

Emerging Technologies

  1. mRNA and Next-Gen Platforms
  • Rapid response to emerging pathogens.
  • Potential for cancer and personalized medicine.
     2. Nanoparticle Vaccines
  • Enhanced stability and targeted delivery.
     3. Edible Vaccines
  • Under research for ease of administration and cost-effectiveness.
     4. Artificial Intelligence in Vaccine Design
  • AI aids in predicting effective antigens and streamlining trials.

Comments

Post a Comment

Popular posts from this blog

ONCOLOGY_2_MELANOMA

-
Image
Hi Folks!! Follow our blog on Instagram  LAB IN THE BOX MELANOMA What is Melanoma? Melanoma is a form of skin cancer arising from melanocytes, the pigment-producing cells in the skin. While it is less common than other skin cancers, it is significantly more dangerous due to its ability to spread (metastasize) to other parts of the body if not caught early. Causes and Risk Factors The primary cause of melanoma is exposure to ultraviolet (UV) radiation from the sun or tanning beds. Factors that increase the risk of melanoma include: - Fair Skin : Less melanin provides less protection from UV radiation. - History of Sunburns : Severe, blistering sunburns, especially in early life, increase risk. - Excessive UV Exposure : Frequent use of tanning beds or extensive sun exposure. - Family History : A family history of melanoma increases risk. - Moles : Having many moles or unusual moles can be a risk factor. - Weakened Immune System : Immunocompromised individuals are at higher risk. Sign...
Read more

Warmer climate may Drive Fungi to be more dangerous to our Health!!

-
Image
  Warmer climate may Drive Fungi to be more dangerous to our Health!! The world is filled with tiny creatures that sometimes found it delicious. Bacteria and viruses are so obvious that they are pathogenic . However recent news from Duke University School of medicine found that raised temperature  cause a pathogenic fungus known as Cryptococcus deneoformans to turn its adaptative responses into overdrive. This increases its number of genetic changes, some of which might presumably lead to higher heat resistance, and others perhaps toward greater disease-causing potential . " Fungal diseases are on the rise, largely because of an increase in the number of people who have weakened immune systems or underlying health conditions," Gusa said. But at the same time, pathogenic fungi may be adapting to warmer temperatures as well. Materials  provided by  Duke University .                             ...
Read more

History of Biotechnology

-
Image
HISTORY OF BIOTECHNOLOGY: People have been harnessing biological processes to improve their quality of life for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans began to tap the biological processes of microorganisms in order to make bread, alcoholic beverages, and cheese and to preserve dairy products. But such processes are not what is meant today by biotechnology, a term first widely applied to the molecular and cellular technologies that began to emerge in the 1960s and ’70s. A fledgling “biotech” industry began to coalesce in the mid- to late 1970s, led by Genentech, a pharmaceutical company established in 1976 by Robert A. Swanson and Herbert W. Boyer to commercialize the recombinant DNA technology pioneered by Boyer, Paul Berg, and Stanley N. Cohen. Early companies such as Genentech, Amgen, Biogen, Cetus, and Genex began by manufacturing genetically engineered substances primarily for medical and environmental uses. For ...
Read more